A. Fibrinogen B. Thrombin C. P2Y₁₂ subtype of adenosine diphosphate (ADP) D. Protease-activated receptor (PAR-1)

A. 1 month B. 6 months C. 12 months D. 24 months

A. 81 mg daily B. 325 mg daily C. 650 mg daily D. Aspirin is contraindicated with ticagrelor

A. An 85 year old male with no other health problems. B. An 80 year old male presenting with STEMI and history of type II diabetes mellitus. C. A 65 year old female with a history of hemorrhagic stroke. D. A 45 year old female weighing 50 kg with no other health problems.

A. Primary adherence is the time at which the patient picks up the first prescription fill of a new medication. B. Execution/persistence measures long-term medication adherence. C. The Healthy Adherer Effect may be a confounding variable in adherence studies. D. Non-adherence results in increased hospitalization without an increased risk of death.

A. Patients fill prescriptions at the various pharmacies. B. Patients have common medications. C. Patients see various prescribers. D. Patients achieve refill consolidation.

A. Better patient reported adherence in the intervention group. B. A higher rate of 75% or greater Proportion of Days Covered (PDC) for beta-blocker therapy in the intervention group. C. Medication Therapy Management (MTM) resulted in better lipid profiles for patients in the intervention group. D. Medication Therapy Management (MTM) resulted in better blood pressure control in the intervention group.

A. The intervention group received follow-up phone calls after discharge. B. The adherence measure used in the study was Proportion of Days Covered (PDC). C. There was no difference in the rates of adherence between groups. D. The study period was 12 months.

A. Compare the home medications with inpatient medications in order to identify and resolve discrepancies. B. Provide the patient (or family) with written information on the medications at discharge. C. Fax the list of discharge medications to the patients pharmacy. D. Explain the importance of managing medication information to the patient upon discharge.

A. Patients in the intervention group had a lower rate of hospital utilization than those in the usual care group. B. The intervention included an individualized patient booklet called the After Hospital Care Plan (AHCP). C. The intervention included a follow-up phone call by a clinical pharmacist 2 to 4 days after discharge. D. The toolkit can easily translate to various healthcare settings due to multi-site study design.